Multiple sclerosis
Alyssa Nylander, David A Hafler, Alyssa Nylander, David A Hafler
Abstract
Multiple sclerosis (MS) is a multifocal demyelinating disease with progressive neurodegeneration caused by an autoimmune response to self-antigens in a genetically susceptible individual. While the formation and persistence of meningeal lymphoid follicles suggest persistence of antigens to drive the continuing inflammatory and humoral response, the identity of an antigen or infectious agent leading to the oligoclonal expansion of B and T cells is unknown. In this review we examine new paradigms for understanding the immunopathology of MS, present recent data defining the common genetic variants underlying disease susceptibility, and explore how improved understanding of immune pathway disruption can inform MS prognosis and treatment decisions.
Figures




Source: PubMed
Prossimi studi clinici
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Non ancora reclutamentoMalattia di Parkinson (MdP) | Advanced Primary PDCina
-
Carilion ClinicReclutamento
-
Mahidol UniversityNon ancora reclutamentoCancro al seno | Carcinoma duttale in situ
-
Biosensors Europe SANon ancora reclutamentoNSTEMI | Angina instabile (UA) | Angina (stabile)Regno Unito
-
CooperVision International Limited (CVIL)Non ancora reclutamento
-
Shanghai Yueyang Integrated Medicine HospitalReclutamentoSarcopenia nell'anzianoCina
-
University of Management and Technology LahoreNon ancora reclutamentoFarward Head PosturePakistan
-
China National Center for Cardiovascular DiseasesNon ancora reclutamentoPalloncino rivestito di droga | Ultrasuoni intravascolari | De Novo Large Coronary VesselCina
-
Korea University Anam HospitalNon ancora reclutamentoFA - Fibrillazione atrialeCorea del Sud
-
Jijun WangReclutamento
-
DiproBio (Shanghai) Co., Ltd.Non ancora reclutamentoSalute mentale | Stress psicologicoCina
-
Emory UniversityNon ancora reclutamentoCorrelati alla gravidanza | Hypertensive Disorder of Pregnancy (HDP)Stati Uniti